A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Eli Lilly and Company
Varian, a Siemens Healthineers Company
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Palleon Pharmaceuticals, Inc.
Sichuan Enray Pharmaceutical Sciences Company
Elevation Oncology
Intensity Therapeutics, Inc.
NantCell, Inc.
NextCure, Inc.
Eisai Inc.
Massachusetts General Hospital
CytomX Therapeutics
Hoffmann-La Roche
OncoNano Medicine, Inc.
Herlev Hospital
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Medical University of South Carolina
Wake Forest University Health Sciences
Institut Bergonié
National Institutes of Health Clinical Center (CC)
Stanford University
Pfizer
Amgen
Masonic Cancer Center, University of Minnesota
Millennium Pharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
Curis, Inc.
GE Healthcare
INSYS Therapeutics Inc
Altor BioScience
East and North Hertfordshire NHS Trust